DM AE/CI Flashcards
↑/Replaces Insulin Secretion
Insulin
SU
Meglitinides
↓Hepatic Glucose Output
Metformin
↓Glucagon → ↓glucose production
GLP1 agonists
DPP4i
Pramlintide
Slows Gastric Emptying
GLP1 agonists
Pramlintide
↑Glucose Excretion
SGLT2i
↑ Insulin Sensitivity
TZD
Metformin
Biggest ↓A1c
Insulin metformin SU TZD GLP1
Cardiac Benefits
empagliflozin canagliflozin dapagliflozin liraglutide semaglutide exenatide dulaglutide
Weight loss
SGLT2i
GLP1
pramlintide
Cheapest
Metformin
SU
TZD
Greatest Hypoglycemia
Insulin
SU
meglitinides
pramlintide (w/insulin)
Weight gain
Insulin
SU
meglitinide
TZD
Injectable Drugs
Insulin
GLP1
pramlintide
CI: eGFR or CrCl < 30
Metformin
SGLT2i
exenatide
glyburide
CI: HF
TZD
alogliptin
saxagliptin
CI: Peripheral neuropathy, PAD, diabetic foot ulcers
canagliflozin
CI: Gastroparesis / GI disorder
GLP1
pramlintide
CI: Sulfa allergy
SU
Risk of Lactic Acidosis
Metformin
Risk of Hepatotoxicity
TZD
alogliptin
Risk of HoTN, UTI, Ketoacidosis
SGLT2i
Risk of K abnormalities
canagliflozin (↑K)
insulin (↓K)
Risk of Pancreatitis
DPP4i
GLP1
Risk of Hypersensitivity
SU
DPP4i
Insulin
Risk of Cancer
Pioglitazone
Dapagliflozin
GLP1